Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
Gillim-Ross
Laura
L
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Subbarao
Kanta
K
D000914:Antibodies, Viral / Q000276:immunology*; D006801:Humans; D007109:Immunity / Q000276:immunology*; D053122:Influenza A Virus, H3N2 Subtype / Q000201:enzymology / Q000276:immunology*; D053124:Influenza A Virus, H5N1 Subtype / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology; D009439:Neuraminidase / Q000276:immunology*; D011379:Prognosis
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D009439:Neuraminidase